Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
NCT Number: NCT04199624
This study evaluates the use of ascorbic acid, vitamin C, to temporary reduce gastric pH in individuals with omeprazole induced hypochlorhydria. All participants will receive ascorbic acid tablets to measure the change in gastric pH.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Phase 1
Indianapolis, Indiana, 46202, United States
Elevation of gastric pH in patients with hypochlorhydria can reduce the solubility of weakly basic drugs. This may lead to poor and unpredictable systemic exposure for poorly soluble drugs. For example, extent of absorption of the kinase inhibitors, dasatinib (Sprycel) and erlotinib (Tarceva), is reduced by up to 61% and 46% respectively in patients on acid-reducing agents (ARAs). This pilot study is to evaluate the use of ascorbic acid, vitamin C, to temporary reduce gastric pH in individuals with omeprazole induced hypochlorhdyria. Using pH/impedance testing, we are seeking to determine the magnitude and duration of pH change upon administration of 1000 mg of ascorbic acid in healthy subjects with proton-pump inhibitor induced hypochlorhydria. The results from this study will be used to evaluate the use of ascorbic acid as a drug-drug interaction mitigation strategy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Omeprazole twice daily x 5 days
Ascorbic acid x 1 on day 5
Time frame: From time of inpatient appointment to thirteen months after that time point.
Gastric pH measurements will be continuously monitored throughout the study using a catheter-based pH monitoring system. Gastric pH versus time data will be collected for five hours.
Time frame: From time of initial stool drop-off to thirteen months after that time point.
To explore the correlation between physiologic responses in gastric pH with features of the intestinal microbiome and microbial metabolites (e.g. metabolome).
Indiana University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04942652
Achlorhydria, Acid-Base Imbalance
Seoul, Jongno-gu, South Korea
View Trial DetailsNCT00550368
Achlorhydria, Acid-Base Imbalance
Stanford, California, United States
View Trial DetailsNCT01399164
Achlorhydria, Acid-Base Imbalance
Davis, California, United States
View Trial DetailsNCT00582972
Achlorhydria, Acid-Base Imbalance
Madison, Wisconsin, United States
View Trial Details